Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

This study has been completed.
Aalborg Universitetshospital
Information provided by:
Pronova BioPharma Identifier:
First received: February 23, 2006
Last updated: March 10, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)